- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens purchase of Acuson cleared in Germany
The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound
The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound vendor, at $23 a share.
The offer, which would merge the American firm into a wholly owned subsidiary of Siemens and create the world's largest ultrasound company, remains conditional on expiration of the waiting period under U.S. antitrust law.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Researchers Show Higher Breast Cancer Upstaging Rate with 18F-FAPI PET/CT
September 9th 2024The imaging agent 18F-FAPI PET/CT demonstrated greater than a 45 percent higher sensitivity rate in comparison to 18F-FDG PET/CT for the detection of axillary and extraaxillary regional lymph node metastases, according to a lesion-based analysis from a recent study.
